Evidence map›Paper›PMID 36708772›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2023

Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study.

Donia Bouzid, Quentin Le Hingrat, Florian Salipante, Valentine Marie Ferré, Thierry Chevallier, Sarah Tubiana, Jean Christophe Lucet, Christophe Choquet, Yazdan Yazdanpanah, Jean François Timsit and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Donia BouzidUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; Université de Montpellier, VBMI, Inserm U1047, Nîmes, France. Electronic address: donia.bouzid@gmail.com.
Quentin Le HingratUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.
Florian SalipanteDepartment of Biostatistics, Epidemiology, Public Health and Innovation in Methodology, CHU Nîmes, Université de Montpellier, Nîmes, France.
Valentine Marie FerréUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.
Thierry ChevallierDepartment of Biostatistics, Epidemiology, Public Health and Innovation in Methodology, CHU Nîmes, Université de Montpellier, Nîmes, France.
Sarah TubianaUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, Biostatistics, Epidemiology and Clinical Research Department, Bichat-Claude Bernard University Hospital, Paris, France.
Jean Christophe LucetUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, Infectious Disease Department, Bichat-Claude Bernard University Hospital, Paris, France.
Christophe ChoquetAP-HP Nord, Emergency Department, Bichat-Claude Bernard University Hospital, Paris, France.
Yazdan YazdanpanahUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, Infectious Disease Department, Bichat-Claude Bernard University Hospital, Paris, France.
Jean François TimsitUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, ICU Department, Bichat-Claude Bernard University Hospital, Paris, France.
Diane DescampsUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.
Nadhira HouhouUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.
Benoit VisseauxUniversité Paris Cité, INSERM UMR1137, IAME, F-75018 Paris, France; AP-HP Nord, Virology Department, Bichat-Claude Bernard University Hospital, Paris, France.
Paul LoubetUniversité de Montpellier, VBMI, Inserm U1047, Nîmes, France; Department of Infectious and Tropical Diseases, CHU Nîmes, Université de Montpellier, Nîmes, France.
Université Claude Bernard Lyon 1 · FRInserm · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe COVID-19 pandemic has highlighted the high diagnostic accuracy of the nasopharyngeal swab (including in intensive care unit (ICU) patients). This study aimed to compare nasopharyngeal swab and bronchoalveolar lavage (BAL) results for non-SARS-CoV-2 viruses in patients with suspected pneumonia.

methodsA retrospective analysis was performed in one French academic hospital on consecutive adults from 2012 to 2018 and tested nasopharyngeal swab and BAL within 24 hours by using multiplex PCR. The agreement in pathogen detection between nasopharyngeal swab and BAL was evaluated.

resultsPatients were primarily men (n = 178/276, 64.5%), with a median age of 60 years (IQR: 51-68 years). Of the 276 patients, 169 (61%) were admitted to the ICU for acute respiratory distress. We detected at least one respiratory virus in 34.4% of the nasopharyngeal swabs (n = 95/276) and 29.0% of BAL (n = 80/276). Two or more viruses were detected in 2.5% of the nasopharyngeal swabs (n = 7/276) and 2.2% of BAL (n = 6/276). Rhinovirus/enteroviruses were the most frequently detected viral group in 10.2% (n = 29/285) of the nasopharyngeal swabs and 9.5% (n = 27/285) of BAL, followed by influenza A, detected in 5.6% (n = 16/285) of the nasopharyngeal swabs and 4.9% (n = 14/285) of BAL. Overall agreement was 83.7% (n = 231/276 (95% CI [78.7%, 87.7%])) (i.e. same pathogen or pathogen combination was identified in the nasopharyngeal swab and BAL for 231 patients). Rhinovirus/enterovirus (n = 29/231) and respiratory syncytial virus (n = 13/231) had the lowest agreement of 62.1% (n = 18/29 (95% CI [42.4%-78.7%])) and 61.5% (n = 8/13 (95% CI [32.3%-84.9%])), respectively).

conclusionsThere was a good agreement between nasopharyngeal swabs and BAL in detecting respiratory viruses among adult patients with suspected pneumonia. However, these data still encourage BAL in the case of a negative nasopharyngeal swab.

Indexed as

COVID-19VirusesAdultAgedBronchoalveolar LavageHumansMaleMiddle AgedNasopharynxPandemicsRetrospective StudiesBronchoalveolar lavageMultiplex PCRNasopharyngeal swabSyndromic testing

Identifiers

PMID36708772
PMCPMC9873593
OpenAlexW4317936476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.